What will it take to eliminate pediatric HIV? Reaching WHO target rates of mother-to-child HIV transmission in Zimbabwe: a model-based analysis.

The World Health Organization (WHO) has called for the "virtual elimination" of pediatric HIV: a mother-to-child HIV transmission (MTCT) risk of less than 5%. We investigated uptake of prevention of MTCT (PMTCT) services, infant feeding recommendations, and specific drug regimens necessary...

Full description

Bibliographic Details
Main Authors: Andrea L Ciaranello, Freddy Perez, Jo Keatinge, Ji-Eun Park, Barbara Engelsmann, Matthews Maruva, Rochelle P Walensky, Francois Dabis, Jennifer Chu, Asinath Rusibamayila, Angela Mushavi, Kenneth A Freedberg
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2012-01-01
Series:PLoS Medicine
Online Access:http://europepmc.org/articles/PMC3254654?pdf=render
_version_ 1818940467615629312
author Andrea L Ciaranello
Freddy Perez
Jo Keatinge
Ji-Eun Park
Barbara Engelsmann
Matthews Maruva
Rochelle P Walensky
Francois Dabis
Jennifer Chu
Asinath Rusibamayila
Angela Mushavi
Kenneth A Freedberg
author_facet Andrea L Ciaranello
Freddy Perez
Jo Keatinge
Ji-Eun Park
Barbara Engelsmann
Matthews Maruva
Rochelle P Walensky
Francois Dabis
Jennifer Chu
Asinath Rusibamayila
Angela Mushavi
Kenneth A Freedberg
author_sort Andrea L Ciaranello
collection DOAJ
description The World Health Organization (WHO) has called for the "virtual elimination" of pediatric HIV: a mother-to-child HIV transmission (MTCT) risk of less than 5%. We investigated uptake of prevention of MTCT (PMTCT) services, infant feeding recommendations, and specific drug regimens necessary to achieve this goal in Zimbabwe.We used a computer model to simulate a cohort of HIV-infected, pregnant/breastfeeding women (mean age, 24 y; mean CD4, 451/µl; breastfeeding duration, 12 mo). Three PMTCT regimens were evaluated: (1) single-dose nevirapine (sdNVP), (2) WHO 2010 guidelines' "Option A" (zidovudine in pregnancy, infant nevirapine throughout breastfeeding for women without advanced disease, lifelong combination antiretroviral therapy for women with advanced disease), and (3) WHO "Option B" (pregnancy/breastfeeding-limited combination antiretroviral drug regimens without advanced disease; lifelong antiretroviral therapy with advanced disease). We examined four levels of PMTCT uptake (proportion of pregnant women accessing and adhering to PMTCT services): reported rates in 2008 and 2009 (36% and 56%, respectively) and target goals in 2008 and 2009 (80% and 95%, respectively). The primary model outcome was MTCT risk at weaning. The 2008 sdNVP-based National PMTCT Program led to a projected 12-mo MTCT risk of 20.3%. Improved uptake in 2009 reduced projected risk to 18.0%. If sdNVP were replaced by more effective regimens, with 2009 (56%) uptake, estimated MTCT risk would be 14.4% (Option A) or 13.4% (Option B). Even with 95% uptake of Option A or B, projected transmission risks (6.1%-7.7%) would exceed the WHO goal of less than 5%. Only if the lowest published transmission risks were used for each drug regimen, or breastfeeding duration were shortened, would MTCT risks at 95% uptake fall below 5%.Implementation of the WHO PMTCT guidelines must be accompanied by efforts to improve access to PMTCT services, retain women in care, and support medication adherence throughout pregnancy and breastfeeding, to approach the "virtual elimination" of pediatric HIV in Zimbabwe. Please see later in the article for the Editors' Summary.
first_indexed 2024-12-20T06:40:07Z
format Article
id doaj.art-be6656a5a5b140c28240254d1cc86602
institution Directory Open Access Journal
issn 1549-1277
1549-1676
language English
last_indexed 2024-12-20T06:40:07Z
publishDate 2012-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS Medicine
spelling doaj.art-be6656a5a5b140c28240254d1cc866022022-12-21T19:49:53ZengPublic Library of Science (PLoS)PLoS Medicine1549-12771549-16762012-01-0191e100115610.1371/journal.pmed.1001156What will it take to eliminate pediatric HIV? Reaching WHO target rates of mother-to-child HIV transmission in Zimbabwe: a model-based analysis.Andrea L CiaranelloFreddy PerezJo KeatingeJi-Eun ParkBarbara EngelsmannMatthews MaruvaRochelle P WalenskyFrancois DabisJennifer ChuAsinath RusibamayilaAngela MushaviKenneth A FreedbergThe World Health Organization (WHO) has called for the "virtual elimination" of pediatric HIV: a mother-to-child HIV transmission (MTCT) risk of less than 5%. We investigated uptake of prevention of MTCT (PMTCT) services, infant feeding recommendations, and specific drug regimens necessary to achieve this goal in Zimbabwe.We used a computer model to simulate a cohort of HIV-infected, pregnant/breastfeeding women (mean age, 24 y; mean CD4, 451/µl; breastfeeding duration, 12 mo). Three PMTCT regimens were evaluated: (1) single-dose nevirapine (sdNVP), (2) WHO 2010 guidelines' "Option A" (zidovudine in pregnancy, infant nevirapine throughout breastfeeding for women without advanced disease, lifelong combination antiretroviral therapy for women with advanced disease), and (3) WHO "Option B" (pregnancy/breastfeeding-limited combination antiretroviral drug regimens without advanced disease; lifelong antiretroviral therapy with advanced disease). We examined four levels of PMTCT uptake (proportion of pregnant women accessing and adhering to PMTCT services): reported rates in 2008 and 2009 (36% and 56%, respectively) and target goals in 2008 and 2009 (80% and 95%, respectively). The primary model outcome was MTCT risk at weaning. The 2008 sdNVP-based National PMTCT Program led to a projected 12-mo MTCT risk of 20.3%. Improved uptake in 2009 reduced projected risk to 18.0%. If sdNVP were replaced by more effective regimens, with 2009 (56%) uptake, estimated MTCT risk would be 14.4% (Option A) or 13.4% (Option B). Even with 95% uptake of Option A or B, projected transmission risks (6.1%-7.7%) would exceed the WHO goal of less than 5%. Only if the lowest published transmission risks were used for each drug regimen, or breastfeeding duration were shortened, would MTCT risks at 95% uptake fall below 5%.Implementation of the WHO PMTCT guidelines must be accompanied by efforts to improve access to PMTCT services, retain women in care, and support medication adherence throughout pregnancy and breastfeeding, to approach the "virtual elimination" of pediatric HIV in Zimbabwe. Please see later in the article for the Editors' Summary.http://europepmc.org/articles/PMC3254654?pdf=render
spellingShingle Andrea L Ciaranello
Freddy Perez
Jo Keatinge
Ji-Eun Park
Barbara Engelsmann
Matthews Maruva
Rochelle P Walensky
Francois Dabis
Jennifer Chu
Asinath Rusibamayila
Angela Mushavi
Kenneth A Freedberg
What will it take to eliminate pediatric HIV? Reaching WHO target rates of mother-to-child HIV transmission in Zimbabwe: a model-based analysis.
PLoS Medicine
title What will it take to eliminate pediatric HIV? Reaching WHO target rates of mother-to-child HIV transmission in Zimbabwe: a model-based analysis.
title_full What will it take to eliminate pediatric HIV? Reaching WHO target rates of mother-to-child HIV transmission in Zimbabwe: a model-based analysis.
title_fullStr What will it take to eliminate pediatric HIV? Reaching WHO target rates of mother-to-child HIV transmission in Zimbabwe: a model-based analysis.
title_full_unstemmed What will it take to eliminate pediatric HIV? Reaching WHO target rates of mother-to-child HIV transmission in Zimbabwe: a model-based analysis.
title_short What will it take to eliminate pediatric HIV? Reaching WHO target rates of mother-to-child HIV transmission in Zimbabwe: a model-based analysis.
title_sort what will it take to eliminate pediatric hiv reaching who target rates of mother to child hiv transmission in zimbabwe a model based analysis
url http://europepmc.org/articles/PMC3254654?pdf=render
work_keys_str_mv AT andrealciaranello whatwillittaketoeliminatepediatrichivreachingwhotargetratesofmothertochildhivtransmissioninzimbabweamodelbasedanalysis
AT freddyperez whatwillittaketoeliminatepediatrichivreachingwhotargetratesofmothertochildhivtransmissioninzimbabweamodelbasedanalysis
AT jokeatinge whatwillittaketoeliminatepediatrichivreachingwhotargetratesofmothertochildhivtransmissioninzimbabweamodelbasedanalysis
AT jieunpark whatwillittaketoeliminatepediatrichivreachingwhotargetratesofmothertochildhivtransmissioninzimbabweamodelbasedanalysis
AT barbaraengelsmann whatwillittaketoeliminatepediatrichivreachingwhotargetratesofmothertochildhivtransmissioninzimbabweamodelbasedanalysis
AT matthewsmaruva whatwillittaketoeliminatepediatrichivreachingwhotargetratesofmothertochildhivtransmissioninzimbabweamodelbasedanalysis
AT rochellepwalensky whatwillittaketoeliminatepediatrichivreachingwhotargetratesofmothertochildhivtransmissioninzimbabweamodelbasedanalysis
AT francoisdabis whatwillittaketoeliminatepediatrichivreachingwhotargetratesofmothertochildhivtransmissioninzimbabweamodelbasedanalysis
AT jenniferchu whatwillittaketoeliminatepediatrichivreachingwhotargetratesofmothertochildhivtransmissioninzimbabweamodelbasedanalysis
AT asinathrusibamayila whatwillittaketoeliminatepediatrichivreachingwhotargetratesofmothertochildhivtransmissioninzimbabweamodelbasedanalysis
AT angelamushavi whatwillittaketoeliminatepediatrichivreachingwhotargetratesofmothertochildhivtransmissioninzimbabweamodelbasedanalysis
AT kennethafreedberg whatwillittaketoeliminatepediatrichivreachingwhotargetratesofmothertochildhivtransmissioninzimbabweamodelbasedanalysis